CLINICAL & PIPELINE·Drug Approval
Zydus Pharmaceuticals Secures FDA Approval for Generic Succinylcholine Chloride Injection
Zydus Pharmaceuticals received FDA approval for its generic Succinylcholine Chloride injection (ANDA209467) on May 4, 2018. This approval, with an "AP" therapeutic equivalence rating, designates Zydus's product as a reference standard, enhancing market competition and supply chain resilience for this critical neuromuscular blocker. This offers procurement and supply chain leaders a new, therapeutically equivalent option.
90-Day Activity